TNFRSF17 and lung carcinoma: Furthermore, plasma B cells express marker genes CD38, TNFRSF17(BCMA), and IGHG1/IGHG4, which inhibit cell growth in the early stage of NSCLC but play the opposite role of promoting cell growth in advanced tumors, thus exhibiting heterogeneity in lung cancer progression.